MS
Mayur Sanjay Nawale
About Mayur Sanjay Nawale
Data last updated:
Mayur Sanjay Nawale is a Director at Shritik Pharma Private Limited (since 2023). The companies operate in Paper. Earlier, Mayur Sanjay Nawale was a Director at Primiliv Pharmaceuticals Private Limited (from 2018).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 04 Sep 2023 | 2023 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 10 May 2018 | 2017 | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Mayur Sanjay Nawale
| Name | DIN | Company | Designation |
|---|---|---|---|
| Ankit Sanjay Nawale | 10305823 | Shritik Pharma Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Mayur Sanjay Nawale
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Mayur Sanjay Nawale
Mayur Sanjay Nawale currently holds 1 directorship: Shritik Pharma Private Limited (Director, since 04 Sep 2023).
Mayur Sanjay Nawale was first appointed on 10 May 2018 as Director at Primiliv Pharmaceuticals Private Limited. The most recent appointment on record is 04 Sep 2023 at Shritik Pharma Private Limited.
Mayur Sanjay Nawale held 1 earlier board appointment: Primiliv Pharmaceuticals Private Limited (Director, from 10 May 2018).
The current boards of Mayur Sanjay Nawale's companies include Ankit Sanjay Nawale (Shritik Pharma Private Limited).